This open-access, virtual conference is jointly organised by BSAC and GARDP. For ACC2025, the collaborating organisations are CEPID-ARIES and Fiocruz. This conference is RCPath CPD accredited (8 credits).

The coronavirus pandemic was a wake-up call for those inclined to ignore emerging health threats. Looking to the future, whether it be another virus, mental health, or noncommunicable diseases such as diabetes and dementia, the US must consider its options to avoid or at least minimize the impact of health threats with the potential to […]

This virtual conference will explore the current challenges and treatment opportunities for Gram-negative infections. Delegates will, through plenary lectures and debate, learn about clinical presentations of Gram-negatives and the latest in research and development. Dr. Erin Duffy will be a featured presenter during session seven: What Does the Future Look Like? Improving Gram-Negative Treatments.

Workshop objectives are to 1) review knowledge about vaccine durability; 2) identify factors contributing to vaccine durability; 3) explore assays and markers to measure vaccine durability in people; and 4) identify gaps in the knowledge about vaccine durability requiring further research or funding. NIAID program staff are organizing this workshop along with external experts in […]

Join the Center for Global Development for a conversation on new purchasing systems for antimicrobials and the grand bargain stakeholders must strike to govern the global market. This discussion will draw from a new landscape review of antibiotic procurement systems, which synthesized existing research and thinking on how antimicrobials are procured and ways to improve […]

Topic: Vaccines as Tools to Prevent Antimicrobial Resistance: Advances, Challenges and Future Development Purpose: Antimicrobial resistance caused 4.95 million deaths associated with AMR and 1.27 million deaths attributable to AMR in 2019. Vaccines can prevent a proportion of the AMR burden by preventing drug-sensitive and drug-resistant infections, reducing antibiotic use and reducing pathogen transmission and […]

A 30-minute public webinar will be held on June 9, 2022 at 09:00 AM EDT with representatives from CARB-X, BARDA, Wellcome and NIAID to discuss the global health issues of AMR, and how CARB-X and its partners are working together to address them. The webinar celebrates a recent funding announcement in which BARDA and Wellcome […]

Are you developing AMR diagnostics in or for an LMIC? Or do you have a product that could be adapted and tested for use in low resource settings? Pitch your technology and get customer-driven feedback from a panel of global health representatives at the virtual event with FIND, the global alliance for diagnostics and CARB-X. Register to pitch […]

The GRAM report was published in The Lancet on 20 January 2022. The online launch event will explore these compelling new findings on the global burden of AMR and regional patterns and trends for over 88 pathogen-drug combinations; celebrate the global collaboration and 100’s of data partnerships that made this study possible; consider how data […]

CARB-X Compliance Manager, Rose Garson, will join Taslimarif Saiyed, PhD of Centre for Cellular and Molecular Platforms (C-CAMP) to speak on the role that stewardship and access play in combating #AMR. ✏️ Register: https://bit.ly/3o3op9B